• Register
  • Login
  • Subscribe
  • Contact Us

Latest Chloramphenicol Eye Tenders in Kazakhstan 2025

KazakhstanTenders brings you the latest and most relevant Chloramphenicol Eye tenders in Kazakhstan, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Chloramphenicol Eye and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to KazakhstanTenders, users gain unlimited access to public procurement notices related to Chloramphenicol Eye. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Kazakhstan.

Acquisition of Medicines and other Medical Devices, Amt: 150520.00

KZT Ref No.:  119801641

Deadline:  28 May 2025

Acquisition of Medicines (Analogues are Allowed), Amt: 503080.00

KZT Ref No.:  119737115

Deadline:  26 May 2025

Purchase of Medicines, Amt: 124326.00

KZT Ref No.:  119449905

Deadline:  22 May 2025

Acquisition of Drugs, Amt: 34536.00

KZT Ref No.:  119273259

Deadline:  20 May 2025

Acquisition of Drugs, Amt: 284284.00

KZT Ref No.:  119132515

Deadline:  16 May 2025

Medicines (According to Technical Specifications), Amt: 360155.00

KZT Ref No.:  118935903

Deadline:  14 May 2025

Acquisition of Medical Property, Amt: 4859785.00

KZT Ref No.:  118456010

Deadline:  05 May 2025

Medicines and Medical Devices, Amt: 80318.00

KZT Ref No.:  118330721

Deadline:  30 Apr 2025

Medicines and Medical Devices, Amt: 120718.00

KZT Ref No.:  118175336

Deadline:  28 Apr 2025

  Chat with us